Skip to content

SAVIENT PHARMACEUTICALS INC

CIK 0000722104

← back to feed
Revenue (TTM)
$22.77M
+0.6% YoY Q3 Nov 2013
Net Income (TTM)
−$110.01M
+29.4% YoY Q3 Nov 2013
EPS Diluted (TTM)
—
Q3 Nov 2013
Gross Margin
-20.9%
Q3 Nov 2013
Operating Margin
-347.8%
Q3 Nov 2013
Net Margin
-483.1%
Q3 Nov 2013
Free Cash Flow (TTM)
−$101.11M
Q3 Nov 2013
Cash
$28.44M
Q3 Nov 2013
Total Debt
$235.73M
Q3 Nov 2013
Shares Outstanding
73.37M sh
Q3 Nov 2013

Revenue & Net Income

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings